<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The expression of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules on CD34+ cells in <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and B-lineage <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (B-lineage ALL) was compared with that on the myeloid and B-lymphoid CD34+ cells in <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow </plain></SENT>
<SENT sid="1" pm="."><plain>Bone marrow aspirates of 10 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, 8 patients with B-lineage ALL and of 6 healthy volunteers were examined </plain></SENT>
<SENT sid="2" pm="."><plain>The phenotype of the CD34+ cells was determined with a double immunofluorescence method and flow cytometry </plain></SENT>
<SENT sid="3" pm="."><plain>CD34+ cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and B-lineage ALL showed a lower expression of VLA-2 and VLA-3 and a higher expression of ICAM-1 and LFA-3 than their <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow counterparts </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> CD34+ cells had less L-selectin but more VLA-5 on their surface membrane than <z:mpath ids='MPATH_458'>normal</z:mpath> myeloid CD34+ cells </plain></SENT>
<SENT sid="5" pm="."><plain>B-lineage ALL CD34+ cells showed an overexpression of LFA-3 </plain></SENT>
<SENT sid="6" pm="."><plain>In individual patients deficiencies or over-expression of the beta1 integrin chain, VLA-4, PECAM-1 or HCAM also occurred </plain></SENT>
<SENT sid="7" pm="."><plain>An abnormal adhesive capacity of the leukemic cells may influence their proliferation, their localisation and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>An aberrant expression of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules may be used for the detection of minimal residual <z:hpo ids='HP_0001909'>leukemia</z:hpo> in these patients </plain></SENT>
</text></document>